Overview

Aldosterone and the Metabolic Syndrome

Status:
Completed
Trial end date:
2013-09-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the effects of mineralocorticoid receptor (MR) antagonism and renin inhibition on glucose metabolism in humans.
Phase:
Phase 1
Details
Lead Sponsor:
Vanderbilt University
Vanderbilt University Medical Center
Treatments:
Hydrochlorothiazide
Insulin
Lactitol
Spironolactone